Valuation: LifeVantage Corporation

Market Cap 84.02M 72.89M 68.34M 62.26M 117M 8.01B 119M 805M 314M 4.01B 315M 309M 13.39B P/E 2026 *
15.9x
P/E 2027 * 17.1x
Enterprise Value 70.47M 61.13M 57.32M 52.22M 98.24M 6.72B 99.78M 675M 263M 3.36B 265M 259M 11.23B EV / Sales 2026 *
0.38x
EV / Sales 2027 * 0.39x
Free-Float
87.97%
Yield 2026 *
-
Yield 2027 * -
1 day-2.25%
1 week-4.69%
Current month+1.24%
1 month+4.33%
3 months+26.65%
6 months+27.90%
Current year+5.68%
1 week 6.32
Extreme 6.32
6.97
1 month 5.82
Extreme 5.82
6.97
Current year 3.9
Extreme 3.9
11.71
1 year 3.9
Extreme 3.9
15
3 years 3.9
Extreme 3.9
27.38
5 years 3.04
Extreme 3.04
27.38
10 years 2.86
Extreme 2.86
27.38
Manager TitleAgeSince
Chief Executive Officer 63 05/08/2026
Director of Finance/CFO 53 25/10/2021
Chief Tech/Sci/R&D Officer - 07/01/2026
Director TitleAgeSince
Director/Board Member 67 01/02/2017
Director/Board Member 68 17/02/2022
Chairman 63 27/11/2023
Date Insider Type Main position Quantity % Market Cap.
06/08/26 Free

Chief Executive Officer

848,765 6.7278%
01/07/26 Tax

Chief Financial Officer

-1,361 0.0108%
01/07/26 Tax

Responsable ventes & marketing

-1,717 0.0136%
Change 5-day change 1-year change 3-year change Capi.($)
-2.25%-4.69%-52.69%+31.78% 84.02M
+0.43%+9.38%+92.10%+130.99% 1,083B
+0.41%+2.33%+50.07%+50.05% 626B
-0.53%+2.03%+25.23%+63.46% 442B
-0.92%+2.18%+48.40%+37.85% 363B
-1.32%-0.32%+29.35%+36.81% 295B
-1.20%-0.32%+6.03%+6.09% 248B
+0.45%+6.71%+45.98%+58.54% 224B
-2.51%-2.63%-7.16%-51.74% 210B
+0.07%+0.46%+12.78%+69.84% 168B
Average -0.76%+2.34%+25.01%+43.37% 365.92B
Weighted average by Cap. -0.29%+4.29%+49.44%+65.96%

Financials

2026 *2027 *
Net sales 184M 160M 150M 136M 257M 17.56B 261M 1.77B 688M 8.79B 692M 676M 29.35B 178M 155M 145M 132M 249M 17B 253M 1.71B 666M 8.52B 670M 655M 28.42B
Net income 5.3M 4.6M 4.31M 3.93M 7.39M 505M 7.5M 50.79M 19.79M 253M 19.9M 19.46M 845M 4.9M 4.25M 3.99M 3.63M 6.83M 467M 6.94M 46.96M 18.29M 234M 18.4M 18M 781M
Net Debt -13.55M -11.75M -11.02M -10.04M -18.89M -1.29B -19.18M -130M -50.59M -647M -50.87M -49.76M -2.16B -15M -13.01M -12.2M -11.11M -20.9M -1.43B -21.23M -144M -55.98M -716M -56.3M -55.07M -2.39B
Logo LifeVantage Corporation
LifeVantage Corporation is an activation company, which is engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.
Employees
235
Date Price Change Volume
12/08/26 $6.510 -2.25% 81,845
11/08/26 $6.660 -0.30% 72,494
10/08/26 $6.680 -1.18% 54,239
07/08/26 $6.760 +2.74% 50,176
06/08/26 $6.580 -1.20% 46,854
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
6.510USD
Average target price
7.000USD
Spread / Average Target
+7.53%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LFVN Stock